The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 28 of the 38 sources its claims cite were checked for support.
Effectiveness and Minimum Effective Dose of App-Based Mobile Health Interventions for Anxiety and Depression Symptom Reduction: Systematic Review and Meta-Analysis
Open accessAbstract
Background: Mobile health (mHealth) apps offer new opportunities to deliver psychological treatments for mental illness in an accessible, private format. The results of several previous systematic reviews support the use of app-based mHealth interventions for anxiety and depression symptom management. However, it remains unclear how much or how long the minimum treatment “dose” is for an mHealth intervention to be effective. Just-in-time adaptive intervention (JITAI) has been introduced in the mHealth domain to facilitate behavior changes and is positioned to guide the design of mHealth interventions with enhanced adherence and effectiveness. Objective: Inspired by the JITAI framework, we conducted a systematic review and meta-analysis to evaluate the dose effectiveness of app-based mHealth interventions for anxiety and depression symptom reduction. Methods: We conducted a literature search on 7 databases (ie, Ovid MEDLINE, Embase, PsycInfo, Scopus, Cochrane Library (eg, CENTRAL), ScienceDirect, and ClinicalTrials, for publications from January 2012 to April 2020. We included randomized controlled trials (RCTs) evaluating app-based mHealth interventions for anxiety and depression. The study selection and data extraction process followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We estimated the pooled effect size using Hedge g and appraised study quality using the revised Cochrane risk-of-bias tool for RCTs. Results: We included 15 studies involving 2627 participants for 18 app-based mHealth interventions. Participants in the intervention groups showed a significant effect on anxiety (Hedge g=–.10, 95% CI –0.14 to –0.06, I2=0%) but not on depression (Hedge g=–.08, 95% CI –0.23 to 0.07, I2=4%). Interventions of at least 7 weeks’ duration had larger effect sizes on anxiety symptom reduction. Conclusions: There is inconclusive evidence for clinical use of app-based mHealth interventions for anxiety and depression at the current stage due to the small to nonsignificant effects of the interventions and study quality concerns. The recommended dose of mHealth interventions and the sustainability of intervention effectiveness remain unclear and require further investigation. © 2022 The Authors. All rights reserved.
Overview
CoChat Summary
## TL;DR
This systematic review and meta-analysis found that app-based mHealth interventions had a small but statistically significant effect on anxiety, but not on depression when compared with control groups. The authors concluded that clinical use cannot yet be recommended because effects were small or nonsignificant, study quality was mixed, and the minimum effective dose remains unclear.
## Key findings
- The review included 15 studies with 2,627 participants covering 18 app-based mHealth interventions; 15 studies were included in the meta-analysis and 3 were excluded because they did not report data for meta-analysis.
- Compared with control groups at intervention end, app-based interventions showed a significant effect on anxiety (Hedge g = –0.10, 95% CI –0.14 to –0.05, I² = 0%) but not on depression (Hedge g = –0.08, 95% CI –0.23 to 0.07, I² = 4%).
- Compared with preintervention baseline, the interventions showed significant reductions in both anxiety (Hedge g = –0.20, 95% CI –0.31 to –0.09) and depression (Hedge g = –0.25, 95% CI –0.39 to –0.11).
- Dose analysis suggested interventions longer than 7 weeks had larger effects on anxiety reduction, while depression showed no clear dose-dependent trend; follow-up effects for both anxiety and depression were not significant and reduced over time.
## Methods
- Design: Systematic review and meta-analysis reported according to PRISMA guidelines.
- Data/sample: Search of 7 databases for studies published from January 2012 to April 2020; included randomized controlled trials of app-based mHealth interventions for anxiety and/or depression published in English.
- Main analysis: Computed pooled effects using Hedge g with random-effect and fixed-effect models, assessed heterogeneity with I², evaluated publication bias with funnel plots and the Egger test, and appraised study quality with RoB 2.
## Limitations
- The paper states that the literature search was restricted to English publications, and that there was a small amount of research available relative to other meta-analyses.
- The authors note that included studies used various outcome measures, and they extracted only the primary or secondary measures for anxiety and depression, which may have missed effects detected by other measures.
- The authors say incomplete and inconsistent reporting of intervention dose design and exposure limited the quantitative analysis of optimal dose; they also note that most studies reported no data on actual intervention exposure.
- Evident from the text: blinding of outcome assessment was not possible for most studies because outcomes were self-reported, and most studies were rated as “some concerns” or “high risk of bias”.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
12 Valid · 2 Not valid · 6 Not checked · 37 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“The finding is inconsistent with other systematic reviews reporting that smartphone apps have small-to-moderate effect sizes on depression symptom reduction [4,10,12].”
§ Effectiveness and Minimum Effective Dose of App-Based Mobile Health Interventions for Anxiety and Depression Symptom Reduction: Systematic Review and Meta-Analysis > Discussion > Principal Findings
What the sources say
- Supportedcites [4] source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Not checked — no full text of the sourcecites [10] source
- Disputedcites [12] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 1 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Several previous systematic reviews and meta-analyses have supported the use of app-based mHealth interventions for anxiety and depression symptom management.”
§ Effectiveness and Minimum Effective Dose of App-Based Mobile Health Interventions for Anxiety and Depression Symptom Reduction: Systematic Review and Meta-Analysis > Introduction
What the sources say
- Not checked — no full text of the sourcecites [10] source
- Partly supportedcites [11] sourceExperimental — accuracy not yet measured
The Discussion (page not provided) reports that smartphone interventions reduced anxiety symptoms compared with control conditions, supporting the anxiety portion of the claim. This review evaluates anxiety outcomes, including in studies targeting other disorders; it does not establish that app-based interventions manage depression symptoms. (LLM, conf=0.88)
- Supportedcites [12] source
The Introduction reports previous systematic and meta-analytic reviews finding small reductions in anxiety scores and depressive symptoms with smartphone interventions compared with controls. It cautions that those reviews included apps not primarily designed for anxiety or depression, so their findings do not establish the efficacy of disorder-specific apps. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“All 3 studies reported positive results toward the effects of smartphone apps facilitating CBT on mental illness.”
§ Effectiveness and Minimum Effective Dose of App-Based Mobile Health Interventions for Anxiety and Depression Symptom Reduction: Systematic Review and Meta-Analysis > Discussion > Principal Findings
What the sources say
- Supportedcites [47] source
The Methods section describes this study’s Run4Love intervention as a cognitive-behavioral stress-management course delivered through WeChat to participants with mobile phones. The Results section reports significant reductions in depressive symptoms and perceived stress. This paper supports the positive result for the study it represents among the three cited studies. (LLM, conf=0.88)
- Supportedcites [48] source
The Results section (Key Outcome: Symptom Change; page not provided) reports that participants using the CBT-based Pacifica app improved more than waitlist controls on depression, anxiety, and stress. This supports the cited paper’s contribution to the statement that the studies reported positive results; it does not establish the results of the other two studies. (LLM, conf=0.91)
- Partly supportedcites [49] sourceExperimental — accuracy not yet measured
The Results > Depression Outcomes section reports better outcomes for the problem-solving app than for the control among participants with moderate depression. But Methods > Intervention Apps describes the interventions as problem-solving therapy and cognitive-control training, not CBT; this single trial also cannot establish the results of all three studies mentioned in the citing sentence. No page numbers are available in our copy. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Finally, we computed the pooled effect size of the mHealth interventions during the follow-up period to uncover the sustainability of the intervention effects on anxiety and depression reduction, which was not revealed in previous systematic reviews focusing on a similar topic [10-12].”
§ Effectiveness and Minimum Effective Dose of App-Based Mobile Health Interventions for Anxiety and Depression Symptom Reduction: Systematic Review and Meta-Analysis > Discussion > Limitations and Strengths Our review has several limitations that should be considered when interpreting the results. First, our literature search was restricted to English publications and resulted in a small amount of research available compared to other meta-analyses examining the evidence of smartphone-based interventions for mental illness. Second, the included studies used various outcome measures, and we extracted only the primary or secondary measures for anxiety and depression. Although this strategy was used in previous systematic reviews and meta-analyses on similar topics, we might have missed the effects detected by other measures. Both limitations might result in our findings of limited or nonexistent efficacy of the interventions and confidence reduction in our dose analysis results. Finally, we included 6 studies that delivered their interventions in part by smartphone. Although app components were the main parts of their interventions, our results may not represent the effects of stand-alone smartphone apps due to the inclusion of the studies. Nevertheless, we decided to include these studies because we considered these interventions were still app-based mHealth interventions. In addition, small effect sizes for 4 of the 6 studies suggest that the nonapp components do not seem to contribute to the primary effect. Further studies, including more studies for blended interventions (smartphone app + other intervention components), are needed to compare the effects of stand-alone smartphone apps and blended interventions on mental illness management. Despite the limitations, this review has many strengths. First, our included studies covered several publications that were published after 2019 [32-34,38,44] to reflect updated evidence, which can support future development and use of app-based mHealth interventions for anxiety and depression. Second, we conducted several analyses assessing pooled intervention effects at various study time points to understand the effective length of app-based mHealth interventions. Finally, we computed the pooled effect size of the mHealth interventions during the follow-up period to uncover the sustainability of the intervention effects on anxiety and depression reduction, which was not revealed in previous systematic reviews focusing on a similar topic [10-12]. These analyses provide innovative insights informing the future study design of app-based mHealth interventions assessing for anxiety and depression symptom reduction.
What the sources say
- Not checked — no full text of the sourcecites [10] source
- Partly supportedcites [11] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Supportedcites [12] source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All studies reported adequate randomization sequence generation and allocation concealment.”
§ Effectiveness and Minimum Effective Dose of App-Based Mobile Health Interventions for Anxiety and Depression Symptom Reduction: Systematic Review and Meta-Analysis > Results > Risk-of-Bias Assessment
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
19 more claims
Create a free account to see all 57 claims and every source verdict.
- Probably not a substantial claim. 21
- It may state two separate claims as one. 16
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“multiple mobile applications support tracking and management of symptoms common during BZD tapering (e.g., sleep impairment, anxiety, depression).204–208”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [206]
Experimental — accuracy not yet measured
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1×
“Study heterogeneity is considered low when I 2 <25%, moderate when I 2 ranges from 25%-75%, and high when I 2 >75% [27].”
RoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787 · cited 1×
“We used the revised Cochrane risk-of-bias tool for randomized trials (RoB 2) [26] to assess each included study in 5 domains: (1) risk of bias arising from the randomization process, (2) risk of bias due to deviations from the intended interventions (effect of assignment to intervention), (3) risk…”
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099 · cited 1×
“The pooled effect accounting for missing studies was assessed using the Duval and Tweedie trim-and-fill analysis [29].”
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Nahum-Shani, I., Smith, S. N., Spring, B. J., Collins, L. M., Witkiewitz, K., Tewari, A., & Murphy, S. A. (2018) · Annals of Behavioral Medicine · doi:10.1007/s12160-016-9830-8 · Cited by 2,171 · cited 4×
“Just-in-time adaptive intervention (JITAI) has been introduced in the mHealth domain to facilitate behavior changes; it proposes the use of ongoing information (individuals’ changing status) to adapt the delivery of the intervention in its type, timing, or amount (intensity) [13].”
InfluentialHeron, K. E., & Smyth, J. M. (2010) · British Journal of Health Psychology · doi:10.1348/135910709x466063 · Cited by 1,438 · cited 1×
“JITAI has been used to support health behaviors changes, such as physical activity [15,16], healthy diet [17,18], weight loss [19], and addiction [20-22].”
Firth, J., Torous, J., Nicholas, J., Carney, R., Pratap, A., Rosenbaum, S., & Sarris, J. (2017) · World Psychiatry · doi:10.1002/wps.20472 · Cited by 1,097 · cited 5×
“Firth et al [10,11] have reported a small-to-moderate effect size for both anxiety and depression symptom reduction following interventions delivered fully or partially by smartphone compared to control groups (anxiety: Hedge g=.33, 95% CI 0.17-0.48, P <.01; depression: Hedge g=.38, 95% CI…”
InfluentialLinardon, J., Cuijpers, P., Carlbring, P., Messer, M., & Fuller‐Tyszkiewicz, M. (2019) · World Psychiatry · doi:10.1002/wps.20673 · Cited by 860 · cited 3×
“Mobile health (mHealth) apps leverage the ubiquity of mobile devices and the mobile-cellular telecommunication infrastructure and offer new opportunities to deliver psychological treatments for mental illness in an accessible, private format [4].”
Svetkey, L. P. (2008) · JAMA · doi:10.1001/jama.299.10.1139 · Cited by 748
Cited by
App-Based Interventions for Moderate to Severe Depression: A Systematic Review and Meta-Analysis
Bae, H., Shin, H., Ji, H.-G., Kwon, J. S., Kim, H., & Hur, J. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.44120 · Cited by 51
An umbrella review of effectiveness and efficacy trials for app-based health interventions
Chong, S. O. K., Pedron, S., Abdelmalak, N., Laxy, M., & Stephan, A. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00981-x · Cited by 57
“Further reviews reported on depressive 28,43,49 , mania and psychotic symptoms as well as adverse events 28 and anxiety symptoms 43,49 in samples that did include depression patients, however not exclusively.”
BackgroundBrunner, E., Chen, C.-Y. A., Klein, T., Maust, D., Mazer-Amirshahi, M., Mecca, M., Najera, D., Ogbonna, C., Rajneesh, K. F., Roll, E., et al. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09499-2 · Cited by 51
von Lützow, U., Neuendorf, N. L., & Scherr, S. (2025) · BMJ Mental Health · doi:10.1136/bmjment-2025-301641 · Cited by 29
“45 While previous reviews (eg, Lu and colleagues 10 ) reported diminishing effects over time, our findings suggest that current JITAIs/EMIs—particularly those with complex, adaptive decision rules—may offer greater ecological validity and longer-lasting impact.”
Bress, J. N., Falk, A. E., Schier, M. M., Jaywant, A., Moroney, E., Dargis, M. A., Bennett, S. M., Scult, M. A., Volpp, K. G. M., Asch, D. A., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.28372 · Cited by 40
Metadata
- Authors
- Lu, S.-C., Xu, M., Wang, M., Hardi, A., Cheng, A. L., Chang, S.-H., & Yen, P.-Y.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Southern California (US)
- Washington University in St. Louis (US)
- BJC HealthCare (US)
- Corresponding author
- Lu, Sheng-Chieh
- Venue
- JMIR Mental Health
- Publisher
- JMIR Publications Inc.
- Published
- 2022-09-07
- Volume
- 9
- Issue
- 9
- Pages
- e39454
- ISSN
- 2368-7959 (ISSN-L)
- PMC
- PMC9494214
- OpenAlex
- W4294916203
- Cited by
- 45
- References
- 51
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 12 · 2023: 7 · 2022: 1
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- JMIR Mental Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Mental Health Research Topics
- Keywords
- mobile health apps, mobile health intervention, anxiety, depression, symptom relief, minimum effective dose, intervention duration, just-in-time adaptive interventions, digital mental health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness and Minimum Effective Dose of App-Based Mobile Health Interventions for Anxiety and Depression Symptom Reduction: Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.2196/39454
- The paper
- Lu, S.-C., Xu, M., Wang, M., Hardi, A., Cheng, A. L., Chang, S.-H., & Yen, P.-Y. (2022). Effectiveness and Minimum Effective Dose of App-Based Mobile Health Interventions for Anxiety and Depression Symptom Reduction: Systematic Review and Meta-Analysis. JMIR Mental Health. https://doi.org/10.2196/39454
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.